Related references
Note: Only part of the references are listed.Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection
P. R. A. Buijs et al.
CANCER GENE THERAPY (2014)
Stable, High-Level Expression of Reporter Proteins from Improved Alphavirus Expression Vectors To Track Replication and Dissemination during Encephalitic and Arthritogenic Disease
Chengqun Sun et al.
JOURNAL OF VIROLOGY (2014)
Smac mimetics and innate immune stimuli synergize to promote tumor death
Shawn T. Beug et al.
NATURE BIOTECHNOLOGY (2014)
Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer
Charles G. Drake et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
New viruses for cancer therapy: meeting clinical needs
Tanner S. Miest et al.
NATURE REVIEWS MICROBIOLOGY (2014)
Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model
Tooba A. Cheema et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Translational repression precedes and is required for ZAP-mediated mRNA decay
Yiping Zhu et al.
EMBO JOURNAL (2012)
Enhancing Chemosensitivity in ABCB1-and ABCG2-Overexpressing Cells and Cancer Stem-like Cells by An Aurora Kinase Inhibitor CCT129202
Chao Cheng et al.
MOLECULAR PHARMACEUTICS (2012)
Oncolytic virotherapy
Stephen J. Russell et al.
NATURE BIOTECHNOLOGY (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Virus-Tumor Interactome Screen Reveals ER Stress Response Can Reprogram Resistant Cancers for Oncolytic Virus-Triggered Caspase-2 Cell Death
Douglas J. Mahoney et al.
CANCER CELL (2011)
Intelligent Design: Combination Therapy With Oncolytic Viruses
Kathryn Ottolino-Perry et al.
MOLECULAR THERAPY (2010)
Alphavirus M1 induces apoptosis of malignant glioma cells via downregulation and nucleolar translocation of p21WAF1/CIP1 protein
Jun Hu et al.
CELL CYCLE (2009)
Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways
Shruthi Naik et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Characteristics of alpha/beta interferon induction after infection of murine fibroblasts with wild-type and mutant alphaviruses
Crystal W. Burke et al.
VIROLOGY (2009)
Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers
Joseph G. Sinkovics et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2008)
Complete sequence characterization of isolates of Getah virus (genus Alphavirus, family Togaviridae) from China
You-gang Zhai et al.
JOURNAL OF GENERAL VIROLOGY (2008)
ZAP-mediated mRNA degradation
Yiping Zhu et al.
RNA BIOLOGY (2008)
Genomic analysis of a Chinese isolate of Getah-like virus and its phylogenetic relationship with other Alphaviruses
Jin-Sheng Wen et al.
VIRUS GENES (2007)
Identification and characterization of interferon-induced proteins that inhibit alphavirus replication
Yugen Zhang et al.
JOURNAL OF VIROLOGY (2007)
Signal integration in the endoplasmic reticulum unfolded protein response
David Ron et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Inhibition of filovirus replication by the zinc finger antiviral protein
Stefanie Mueller et al.
JOURNAL OF VIROLOGY (2007)
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress
Ta-Chiang Liu et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
The zinc-finger antiviral protein recruits the RNA processing exosome to degrade the target mRNA
Xuemin Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Formation of nsP3-specific protein complexes during Sindbis virus replication
E Frolova et al.
JOURNAL OF VIROLOGY (2006)
From acute ER stress to physiological roles of the Unfolded Protein Response
J Wu et al.
CELL DEATH AND DIFFERENTIATION (2006)
Translational resistance of late alphavirus mRNA to eIF2 alpha phosphorylation: a strategy to overcome the antiviral effect of protein kinase PKR
I Ventoso et al.
GENES & DEVELOPMENT (2006)
Mechanisms of type-I- and type-II-interferon-mediated signalling
LC Platanias
NATURE REVIEWS IMMUNOLOGY (2005)
Roles of CHOP/GADD153 in endoplasmic reticulum stress
S Oyadomari et al.
CELL DEATH AND DIFFERENTIATION (2004)
Systemic tumor targeting and killing by Sindbis viral vectors
JC Tseng et al.
NATURE BIOTECHNOLOGY (2004)
Expression of the zinc-finger antiviral protein inhibits alphavirus replication
MJ Bick et al.
JOURNAL OF VIROLOGY (2003)
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
DF Stojdl et al.
CANCER CELL (2003)
Armed therapeutic viruses: Strategies and challenges to arming oncolytic viruses with therapeutic genes
TW Hermiston et al.
CANCER GENE THERAPY (2002)
Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein
GX Gao et al.
SCIENCE (2002)
Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers
AL Pecora et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Organelle-specific initiation of cell death pathways
KF Ferri et al.
NATURE CELL BIOLOGY (2001)
Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or Myc function and involves the induction of apoptosis
S Balachandran et al.
JOURNAL OF VIROLOGY (2001)
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
DF Stojdl et al.
NATURE MEDICINE (2000)
Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response
A Bertolotti et al.
NATURE CELL BIOLOGY (2000)
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β
T Nakagawa et al.
NATURE (2000)
Share Paper
